-+ 0.00%
-+ 0.00%
-+ 0.00%

Alnylam Pharmaceuticals Price Target Raised to $415.00/Share From $390.00 by Canaccord Genuity

Dow Jones·08/01/2025 15:08:00

Please log in to view news